These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 27657350)

  • 21. Treatment of symptomatic diabetic peripheral neuropathy with the protein kinase C beta-inhibitor ruboxistaurin mesylate during a 1-year, randomized, placebo-controlled, double-blind clinical trial.
    Vinik AI; Bril V; Kempler P; Litchy WJ; Tesfaye S; Price KL; Bastyr EJ;
    Clin Ther; 2005 Aug; 27(8):1164-80. PubMed ID: 16199243
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A double-blind, parallel-group, placebo-controlled, multicentre study of acetyl L-carnitine in the symptomatic treatment of antiretroviral toxic neuropathy in patients with HIV-1 infection.
    Youle M; Osio M;
    HIV Med; 2007 May; 8(4):241-50. PubMed ID: 17461852
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chemotherapy-induced polyneuropathy: major agents and assessment by questionnaires.
    Zedan AH; Vilholm OJ
    Basic Clin Pharmacol Toxicol; 2014 Aug; 115(2):193-200. PubMed ID: 24796774
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vivo detection of nerve injury in familial amyloid polyneuropathy by magnetic resonance neurography.
    Kollmer J; Hund E; Hornung B; Hegenbart U; Schönland SO; Kimmich C; Kristen AV; Purrucker J; Röcken C; Heiland S; Bendszus M; Pham M
    Brain; 2015 Mar; 138(Pt 3):549-62. PubMed ID: 25526974
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sono-electro-magnetic therapy for treating chronic pelvic pain syndrome in men: a randomized, placebo-controlled, double-blind trial.
    Kessler TM; Mordasini L; Weisstanner C; Jüni P; da Costa BR; Wiest R; Thalmann GN
    PLoS One; 2014; 9(12):e113368. PubMed ID: 25546177
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemotherapy-induced peripheral neuropathy and impact on quality of life 6 months after treatment with chemotherapy.
    Beijers A; Mols F; Dercksen W; Driessen C; Vreugdenhil G
    J Community Support Oncol; 2014 Nov; 12(11):401-6. PubMed ID: 25856013
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selected Risk Nutritional Factors for Chemotherapy-Induced Polyneuropathy.
    Grim J; Ticha A; Hyspler R; Valis M; Zadak Z
    Nutrients; 2017 May; 9(6):. PubMed ID: 28587059
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Linaclotide for irritable bowel syndrome with constipation: a 26-week, randomized, double-blind, placebo-controlled trial to evaluate efficacy and safety.
    Chey WD; Lembo AJ; Lavins BJ; Shiff SJ; Kurtz CB; Currie MG; MacDougall JE; Jia XD; Shao JZ; Fitch DA; Baird MJ; Schneier HA; Johnston JM
    Am J Gastroenterol; 2012 Nov; 107(11):1702-12. PubMed ID: 22986437
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Topical Citrullus colocynthis (bitter apple) extract oil in painful diabetic neuropathy: A double-blind randomized placebo-controlled clinical trial.
    Heydari M; Homayouni K; Hashempur MH; Shams M
    J Diabetes; 2016 Mar; 8(2):246-52. PubMed ID: 25800045
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A randomized, controlled trial of gabapentin enacarbil in subjects with neuropathic pain associated with diabetic peripheral neuropathy.
    Rauck R; Makumi CW; Schwartz S; Graff O; Meno-Tetang G; Bell CF; Kavanagh ST; McClung CL
    Pain Pract; 2013 Jul; 13(6):485-96. PubMed ID: 23186035
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A randomized, double-blind, placebo-controlled, sixteen-week study of subcutaneous golimumab in patients with active nonradiographic axial spondyloarthritis.
    Sieper J; van der Heijde D; Dougados M; Maksymowych WP; Scott BB; Boice JA; Berd Y; Bergman G; Curtis S; Tzontcheva A; Huyck S; Weng HH
    Arthritis Rheumatol; 2015 Oct; 67(10):2702-12. PubMed ID: 26139307
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety of avocado/soybean unsaponifiables in the treatment of symptomatic osteoarthritis of the knee and hip. A prospective, multicenter, three-month, randomized, double-blind, placebo-controlled trial.
    Blotman F; Maheu E; Wulwik A; Caspard H; Lopez A
    Rev Rhum Engl Ed; 1997 Dec; 64(12):825-34. PubMed ID: 9476272
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of lacosamide in diabetic neuropathic pain: an 18-week double-blind placebo-controlled trial of fixed-dose regimens.
    Wymer JP; Simpson J; Sen D; Bongardt S;
    Clin J Pain; 2009 Jun; 25(5):376-85. PubMed ID: 19454870
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A double-blind placebo-controlled randomized trial of adalimumab in the treatment of hidradenitis suppurativa.
    Miller I; Lynggaard CD; Lophaven S; Zachariae C; Dufour DN; Jemec GB
    Br J Dermatol; 2011 Aug; 165(2):391-8. PubMed ID: 21457202
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Evaluation of polyneuropathy severity in chronic renal failure patients on continuous ambulatory peritoneal dialysis or on maintenance hemodialysis].
    Janda K; Stompór T; Gryz E; Szczudlik A; Drozdz M; Kraśniak A; Sułowicz W
    Przegl Lek; 2007; 64(6):423-30. PubMed ID: 18159852
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of pregabalin for peripheral neuropathic pain: results of an 8-week, flexible-dose, double-blind, placebo-controlled study conducted in China.
    Guan Y; Ding X; Cheng Y; Fan D; Tan L; Wang Y; Zhao Z; Hong Z; Zhou D; Pan X; Chen S; Martin A; Tang H; Cui L
    Clin Ther; 2011 Feb; 33(2):159-66. PubMed ID: 21444113
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Brivaracetam as adjunctive treatment for uncontrolled partial epilepsy in adults: a phase III randomized, double-blind, placebo-controlled trial.
    Biton V; Berkovic SF; Abou-Khalil B; Sperling MR; Johnson ME; Lu S
    Epilepsia; 2014 Jan; 55(1):57-66. PubMed ID: 24446953
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety and efficacy of tapentadol ER in patients with painful diabetic peripheral neuropathy: results of a randomized-withdrawal, placebo-controlled trial.
    Schwartz S; Etropolski M; Shapiro DY; Okamoto A; Lange R; Haeussler J; Rauschkolb C
    Curr Med Res Opin; 2011 Jan; 27(1):151-62. PubMed ID: 21162697
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of gabapentin in the management of chemotherapy-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled, crossover trial (N00C3).
    Rao RD; Michalak JC; Sloan JA; Loprinzi CL; Soori GS; Nikcevich DA; Warner DO; Novotny P; Kutteh LA; Wong GY;
    Cancer; 2007 Nov; 110(9):2110-8. PubMed ID: 17853395
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extracorporeal shock wave therapy for chronic painful heel syndrome: a prospective, double blind, randomized trial assessing the efficacy of a new electromagnetic shock wave device.
    Gollwitzer H; Diehl P; von Korff A; Rahlfs VW; Gerdesmeyer L
    J Foot Ankle Surg; 2007; 46(5):348-57. PubMed ID: 17761319
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.